Safety and Pharmacology of Oseltamivir in Clinical Use.
- Published in:
- Drug Safety, 2003, v. 26, n. 11, p. 787, doi. 10.2165/00002018-200326110-00004
- By:
- Publication type:
- Article
Works by Oo, Charles
Results: 13
1
2
Pharmacokinetics of anti-influenza prodrug oseltamivir in children aged 1–5 years.
- Published in:
- European Journal of Clinical Pharmacology, 2003, v. 59, n. 5/6, p. 411, doi. 10.1007/s00228-003-0639-6
- By:
- Publication type:
- Article
3
Oseltamivir Distributes to Influenza Virus Replication Sites in the Middle Ear and Sinuses.
- Published in:
- Clinical Drug Investigation, 2004, v. 24, n. 1, p. 49, doi. 10.2165/00044011-200424010-00006
- By:
- Publication type:
- Article
4
Prediction of Tissue Exposures of Meropenem, Colistin, and Sulbactam in Pediatrics Using Physiologically Based Pharmacokinetic Modeling.
- Published in:
- 2022
- By:
- Publication type:
- journal article
5
Lack of pharmacokinetic interaction between the oral anti-influenza neuraminidase inhibitor prodrug oseltamivir and antacids.
- Published in:
- British Journal of Clinical Pharmacology, 2002, v. 54, n. 4, p. 372, doi. 10.1046/j.1365-2125.2002.01678.x
- By:
- Publication type:
- Article
6
Leveraging the attributes of biologics and small molecules, and releasing the bottlenecks: a new wave of revolution in drug development.
- Published in:
- 2016
- By:
- Publication type:
- Editorial
7
The combination effect of meropenem/sulbactam/polymyxin-B on the pharmacodynamic parameters for mutant selection windows against carbapenem-resistant Acinetobacter baumannii.
- Published in:
- Frontiers in Microbiology, 2022, v. 13, p. 1, doi. 10.3389/fmicb.2022.1024702
- By:
- Publication type:
- Article
8
Metabolomic profiling of polymyxin-B in combination with meropenem and sulbactam against multi-drug resistant Acinetobacter baumannii.
- Published in:
- Frontiers in Microbiology, 2022, v. 13, p. 1, doi. 10.3389/fmicb.2022.1013934
- By:
- Publication type:
- Article
9
A personal perspective of orphan drug development for rare diseases: A golden opportunity or an unsustainable future?
- Published in:
- Journal of Clinical Pharmacology, 2016, v. 56, n. 3, p. 257, doi. 10.1002/jcph.599
- By:
- Publication type:
- Article
10
Does Erythromycin Have Anti-Inflammatory Effects Independent of Its Antimicrobial Action?
- Published in:
- 2012
- By:
- Publication type:
- Letter
11
In vitro and in vivo metabolism of a novel chymase inhibitor, SUN13834, and the predictability of human metabolism using mice with humanized liver.
- Published in:
- Xenobiotica, 2014, v. 44, n. 2, p. 154, doi. 10.3109/00498254.2013.865857
- By:
- Publication type:
- Article
12
CHANGE IN CREATININE CLEARANCE WITH ADVANCING AGE.
- Published in:
- Journal of the American Geriatrics Society, 2002, v. 50, n. 9, p. 1603, doi. 10.1046/j.1532-5415.2002.50422.x
- By:
- Publication type:
- Article
13
QT Correction: Using an Observed Regression Factor Applicable to a Population Subset.
- Published in:
- 2016
- By:
- Publication type:
- journal article